TP53INP2 and B-cell chronic lymphocytic leukemia: We examined the expression of oncogenes from the TP53I and TP53INP families in MEC-1 cells after molidustat treatment and found that the expression levels of TP53I13, TP53I3, TP53INP1, and TP53INP2 remarkably increased, which may lead to the death of CLL cells.